Literature DB >> 19282367

Oncogenic ras blocks the cAMP pathway and dedifferentiates thyroid cells via an impairment of pax8 transcriptional activity.

Maria Giuseppina Baratta1, Immacolata Porreca, Roberto Di Lauro.   

Abstract

A deranged differentiation is often a landmark of transformed cells. We used a thyroid cell line expressing an inducible Ras oncoprotein in order to study the hierarchy of molecular events leading to suppression of thyroid-specific gene expression. We find that, upon Ras activation, there is an immediate global down-regulation of thyroid differentiation, which is associated with an inhibition of the cAMP signaling pathway. We demonstrate that an unusual negative cross talk between Ras oncogene and the cAMP pathway induces inactivation of the transcription factor Pax8 that we propose as a crucial event in Ras-induced dedifferentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282367      PMCID: PMC5419283          DOI: 10.1210/me.2008-0353

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  58 in total

Review 1.  Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

Authors:  M Frödin; S Gammeltoft
Journal:  Mol Cell Endocrinol       Date:  1999-05-25       Impact factor: 4.102

2.  Hormonal regulation of thyroid peroxidase in normal and transformed rat thyroid cells.

Authors:  R Zarrilli; S Formisano; B Di Jeso
Journal:  Mol Endocrinol       Date:  1990-01

3.  DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation.

Authors:  Custodia García-Jiménez; Miguel A Zaballos; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2005-07-14

4.  Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin.

Authors:  Rocco Bruno; Elisabetta Ferretti; Emanuele Tosi; Franco Arturi; Paolo Giannasio; Tiziana Mattei; Angela Scipioni; Ivan Presta; Roberta Morisi; Alberto Gulino; Sebastiano Filetti; Diego Russo
Journal:  J Clin Endocrinol Metab       Date:  2005-08-02       Impact factor: 5.958

Review 5.  What turns CREB on?

Authors:  Mona Johannessen; Marit Pedersen Delghandi; Ugo Moens
Journal:  Cell Signal       Date:  2004-11       Impact factor: 4.315

6.  Dose-dependent inhibition of thyroid differentiation by RAS oncogenes.

Authors:  Gabriella De Vita; Lisa Bauer; Vania M Correa da Costa; Mario De Felice; Maria Giuseppina Baratta; Marta De Menna; Roberto Di Lauro
Journal:  Mol Endocrinol       Date:  2004-09-23

7.  Ki-ras oncogene interferes with the expression of cyclic AMP-dependent promoters.

Authors:  A Gallo; A Feliciello; A Varrone; R Cerillo; M E Gottesman; V E Avvedimento
Journal:  Cell Growth Differ       Date:  1995-01

8.  Ras inhibits thyroglobulin expression but not cyclic adenosine monophosphate-mediated signaling in Wistar rat thyrocytes.

Authors:  E Kupperman; D Wofford; W Wen; J L Meinkoth
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

9.  Thyrotropin stimulation of cultured thyroid cells increases steady state levels of the messenger ribonucleic acid for thyroid peroxidase.

Authors:  G Chazenbalk; R P Magnusson; B Rapoport
Journal:  Mol Endocrinol       Date:  1987-12

10.  The CRE-like element inside the 5'-upstream region of the rat sodium/iodide symporter gene interacts with diverse classes of b-Zip molecules that regulate transcriptional activities through strong synergy with Pax-8.

Authors:  J T Chun; V Di Dato; B D'Andrea; M Zannini; R Di Lauro
Journal:  Mol Endocrinol       Date:  2004-08-19
View more
  5 in total

1.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Wnt-independent role of β-catenin in thyroid cell proliferation and differentiation.

Authors:  Ana Sastre-Perona; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2014-03-19

3.  Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.

Authors:  Aime T Franco; Roberta Malaguarnera; Samuel Refetoff; Xiao-Hui Liao; Emma Lundsmith; Shioko Kimura; Catrin Pritchard; Richard Marais; Terry F Davies; Lee S Weinstein; Min Chen; Neal Rosen; Ronald Ghossein; Jeffrey A Knauf; James A Fagin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.

Authors:  Mahesh Saqcena; Luis Javier Leandro-Garcia; Jesper L V Maag; Vatche Tchekmedyian; Gnana P Krishnamoorthy; Prasanna P Tamarapu; Vera Tiedje; Vincent Reuter; Jeffrey A Knauf; Elisa de Stanchina; Bin Xu; Xiao-Hui Liao; Samuel Refetoff; Ronald Ghossein; Ping Chi; Alan L Ho; Richard P Koche; James A Fagin
Journal:  Cancer Discov       Date:  2020-12-14       Impact factor: 39.397

5.  β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation.

Authors:  Ana Sastre-Perona; Garcilaso Riesco-Eizaguirre; Miguel A Zaballos; Pilar Santisteban
Journal:  Oncotarget       Date:  2016-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.